JP2012501680A5 - - Google Patents

Download PDF

Info

Publication number
JP2012501680A5
JP2012501680A5 JP2011527024A JP2011527024A JP2012501680A5 JP 2012501680 A5 JP2012501680 A5 JP 2012501680A5 JP 2011527024 A JP2011527024 A JP 2011527024A JP 2011527024 A JP2011527024 A JP 2011527024A JP 2012501680 A5 JP2012501680 A5 JP 2012501680A5
Authority
JP
Japan
Prior art keywords
use according
cells
glycerol
cell
cryoprotectant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011527024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012501680A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/056829 external-priority patent/WO2010030986A2/en
Publication of JP2012501680A publication Critical patent/JP2012501680A/ja
Publication of JP2012501680A5 publication Critical patent/JP2012501680A5/ja
Pending legal-status Critical Current

Links

JP2011527024A 2008-09-12 2009-09-14 クリーンゲノムバクトフェクション Pending JP2012501680A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9664908P 2008-09-12 2008-09-12
US61/096,649 2008-09-12
PCT/US2009/056829 WO2010030986A2 (en) 2008-09-12 2009-09-14 Clean genome bactofection

Publications (2)

Publication Number Publication Date
JP2012501680A JP2012501680A (ja) 2012-01-26
JP2012501680A5 true JP2012501680A5 (cg-RX-API-DMAC7.html) 2012-11-01

Family

ID=41328762

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011527024A Pending JP2012501680A (ja) 2008-09-12 2009-09-14 クリーンゲノムバクトフェクション

Country Status (5)

Country Link
US (1) US20110165680A1 (cg-RX-API-DMAC7.html)
EP (1) EP2344646A2 (cg-RX-API-DMAC7.html)
JP (1) JP2012501680A (cg-RX-API-DMAC7.html)
CA (1) CA2736877A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010030986A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20120425A1 (es) * 2009-01-23 2012-05-03 Jackson H M Found Military Med Metodos y composiciones en base a la proteina tipo 2 de la toxina shiga
EP2742127B1 (en) * 2011-08-12 2019-10-09 Mello Biotechnology, Inc. Inducable expression from the eukaryotic pol-2 promoter in prokaryotes
AU2012312805A1 (en) * 2011-09-22 2014-04-10 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Shigella-derived vector and methods of using the same
US11680273B2 (en) 2011-09-23 2023-06-20 Loma Linda University Treatment of autoimmune diseases
DK2758074T3 (da) 2011-09-23 2020-07-27 Univ Loma Linda Bakteriestammer der udtrykker methylasegener og anvendelser deraf
US10196662B2 (en) * 2012-08-10 2019-02-05 Mello Biotechnology, Inc. Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2019205057A1 (zh) * 2018-04-26 2019-10-31 广州中科蓝华生物科技有限公司 一种启动子及其应用
CN109402155A (zh) * 2018-11-12 2019-03-01 川北医学院 一种双控延迟裂解性质粒及其构建方法与应用
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
WO2021058722A1 (en) * 2019-09-25 2021-04-01 Katholieke Universiteit Leuven Large vectors and methods for high-yield production
IL295529A (en) 2020-02-13 2022-10-01 Tenaya Therapeutics Inc Gene therapy vectors for treating heart disease
WO2021231441A1 (en) * 2020-05-11 2021-11-18 University Of Virginia Patent Foundation Compositions and methods for inducing immune responses against class i fusion protein viruses
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
AU2022286964A1 (en) * 2021-06-02 2024-01-18 Sivec Biotechnologies Llc Bacterial delivery of antibodies, antibody derivatives, and polypeptides to eukaryotic cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119365B2 (en) * 2002-01-23 2012-02-21 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US6989265B2 (en) * 2002-01-23 2006-01-24 Wisconsin Alumni Research Foundation Bacteria with reduced genome
EP1915445A2 (en) * 2005-08-20 2008-04-30 Scarab Genomics, LLC Reduced genome e. coli
AU2006325975B2 (en) * 2005-12-13 2011-12-08 Kyoto University Nuclear reprogramming factor
EP2423314A1 (en) * 2006-08-03 2012-02-29 Wisconsin Alumni Research Foundation Vector systems

Similar Documents

Publication Publication Date Title
JP2012501680A5 (cg-RX-API-DMAC7.html)
Matoba et al. Somatic cell nuclear transfer reprogramming: mechanisms and applications
de Figueiredo Pessôa et al. Induced pluripotent stem cells throughout the animal kingdom: availability and applications
Xu et al. Genetic and epigenetic controls of plant regeneration
JP2015165810A5 (cg-RX-API-DMAC7.html)
Ren et al. Generation of hircine-induced pluripotent stem cells by somatic cell reprogramming
Srinageshwar et al. Role of epigenetics in stem cell proliferation and differentiation: implications for treating neurodegenerative diseases
JP2018113985A5 (cg-RX-API-DMAC7.html)
EP2342333A4 (en) Method for producing induced pluripotent stem cells
WO2010030986A3 (en) Clean genome bactofection
JP2016535601A5 (cg-RX-API-DMAC7.html)
Li et al. Fabrication of cellulose aerogel from wheat straw with strong absorptive capacity
Talluri et al. Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons
CN102260646B (zh) 一种制备诱导多潜能干细胞的方法,试剂盒及用途
JP2011529329A5 (cg-RX-API-DMAC7.html)
JP2015516812A5 (cg-RX-API-DMAC7.html)
JP2010521990A5 (cg-RX-API-DMAC7.html)
JP2015506673A5 (cg-RX-API-DMAC7.html)
Choi et al. Reactivation of endogenous genes and epigenetic remodeling are barriers for generating transgene-free induced pluripotent stem cells in pig
Menzorov et al. Comparison of American mink embryonic stem and induced pluripotent stem cell transcriptomes
Swegen et al. Cloning in action: can embryo splitting, induced pluripotency and somatic cell nuclear transfer contribute to endangered species conservation?
Rebuzzini et al. Building pluripotency identity in the early embryo and derived stem cells
Weeratunga et al. Induced pluripotent stem cells from domesticated ruminants and their potential for enhancing livestock production
Petkov et al. Controlling the switch from neurogenesis to pluripotency during marmoset monkey somatic cell reprogramming with self-replicating mRNAs and small molecules
RU2015122802A (ru) Клонированное животное, отличное от человека, которое не содержит селективный маркер